Actively Recruiting
Cancer CARE Beyond Walls In-home Intravesical Therapy for Non-Muscle Invasive Bladder Cancer Phase IbII Single-Arm Trial Comparing Home and Clinic Chemotherapy Delivery
Led by Mayo Clinic · Updated on 2026-10-08
40
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety, tolerability, and acceptability of giving chemotherapy directly into the bladder at home compared to in a clinic for patients with non-muscle invasive bladder cancer. This phase IbII trial aims to see if home treatment can reduce the disruption caused by frequent clinic visits while maintaining safety and patient satisfaction. The study focuses on commonly used chemotherapy drugs like BCG, gemcitabine, docetaxel, and mitomycin C that work by stopping tumor cells from growing or spreading. Participants receive intravesical chemotherapy either as induction or maintenance therapy. During induction, patients get one of the specified chemotherapy drugs in the clinic and then continue treatment at home weekly for up to five weeks if there is no disease progression or unacceptable side effects. In the maintenance phase, patients receive scheduled intravesical chemotherapy at home, varying from weekly to monthly doses over several weeks or months. Patients also undergo cystoscopy at the end of the study and have access to home health visits from Cancer Care Beyond Walls throughout the trial. Throughout the study, participants complete questionnaires about their health, quality of life, and any side effects they experience. Researchers monitor adverse events for 12 weeks and assess the feasibility and patient satisfaction of home treatment up to one year. Follow-up visits occur 12 weeks after starting treatment and continue for up to one year to evaluate disease-free survival and unplanned healthcare interactions. The total participation period extends up to three years with ongoing safety and health status assessments.
CONDITIONS
Brief Title
In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial
Research Team
C
Clinical Trials Referral Office
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here